von Cutanos | Mai 12, 2022 | Uncategorized
We welcome our new CFO/CBO Ulrich Platte The whole team is thrilled to announce Ulrich as our new CFO & CBO. We are beyond confident he will be a major asset to Cutanos and our next business development steps. Welcome, Ulrich!...
von Cutanos | Feb. 12, 2022 | Uncategorized
Cutanos and Pfizer team up to apply LC-TDS technology to autoimmune diseases Thanks to Pfizer’s Emerging Science Fund, Cutanos will explore its immune cell-specific drug delivery system as a potential therapy platform for autoimmune disorders. In the next...
von Cutanos | Jan. 12, 2022 | Uncategorized
We Welcome our Newest Team Members! We are very happy to announce our latest additions to the team: Alexandra Sykora (Office Manager), Mirza Sarcevic and Gabriele Carta (Technical Assistants)! Welcome aboard!...
von Cutanos | Nov. 14, 2021 | Uncategorized
Cutanos joins Green Labs Austria Initiative As a biotechnology lab Cutanos feels responsible to not only contribute to science but also carrying out experiments in a more sustainable fashion. Hence, we want to participate in Green Labs Austria vision to reduce...
von Cutanos | Nov. 12, 2021 | Uncategorized
ABA Podcast „𝗪𝗶𝗿𝘁𝘀𝗰𝗵𝗮𝗳𝘁 𝗶𝗺 ¾ 𝗧𝗮𝗸𝘁“ — Doris Dobida talks with Cutanos‘ Co-Founder Robert Wawrzinek about starting a biotech company in Austria....
von Cutanos | Okt. 12, 2021 | Uncategorized
Specific Protein Antigen Delivery to Human Langerhans Cells in Intact Skin — Mareike Rentzsch, Robert Wawrzinek, Claudia Zelle-Rieser, Helen Strandt, Lydia Bellmann, Felix F. Fuchsberger, Jessica Schulze, Jil Busmann, Juliane Rademacher, Stephan Sigl, Barbara Del...
